Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Trecarichi EM, Giuliano G, Cattaneo C, Ballanti S, Criscuolo M, Candoni A, Marchesi F, Laurino M, Dargenio M, Fanci R, Cefalo M, Delia M, Spolzino A, Maracci L, Bonuomo V, Busca A, Principe MID, Daffini R, Simonetti E, Dragonetti G, Zannier ME, Pagano L, Tumbarello M; Hematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry – Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne (SEIFEM) group, Italy. Trecarichi EM, et al. Among authors: maracci l. Int J Antimicrob Agents. 2023 Jun;61(6):106806. doi: 10.1016/j.ijantimicag.2023.106806. Epub 2023 Apr 6. Int J Antimicrob Agents. 2023. PMID: 37030470 Free article.
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
Trecarichi EM, Giuliano G, Cattaneo C, Ballanti S, Criscuolo M, Candoni A, Marchesi F, Laurino M, Dargenio M, Fanci R, Cefalo M, Delia M, Spolzino A, Maracci L, Nadali G, Busca A, Del Principe MI, Daffini R, Simonetti E, Dragonetti G, Zannier ME, Pagano L, Tumbarello M; Haematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry–Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne (SEIFEM) group, Italy. Trecarichi EM, et al. Among authors: maracci l. PLoS One. 2019 Oct 29;14(10):e0224465. doi: 10.1371/journal.pone.0224465. eCollection 2019. PLoS One. 2019. PMID: 31661507 Free PMC article.
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.
Offidani M, Corvatta L, Maracci L, Liberati AM, Ballanti S, Attolico I, Caraffa P, Alesiani F, Caravita di Toritto T, Gentili S, Tosi P, Brunori M, Derudas D, Ledda A, Gozzetti A, Cellini C, Malerba L, Mele A, Andriani A, Galimberti S, Mondello P, Pulini S, Coppetelli U, Fraticelli P, Olivieri A, Leoni P. Offidani M, et al. Among authors: maracci l. Blood Cancer J. 2013 Nov 22;3(11):e162. doi: 10.1038/bcj.2013.58. Blood Cancer J. 2013. PMID: 24270324 Free PMC article.
Stem Cell Transplantation in Multiple Myeloma.
Offidani M, Gentili S, Gay F, Aghemo E, Maracci L, Corvatta L, Palumbo A. Offidani M, et al. Among authors: maracci l. Curr Cancer Drug Targets. 2017;17(9):769-781. doi: 10.2174/1568009616666160920090236. Curr Cancer Drug Targets. 2017. PMID: 27659429 Review.
Oral ixazomib maintenance therapy in multiple myeloma.
Offidani M, Corvatta L, Gentili S, Maracci L, Leoni P. Offidani M, et al. Among authors: maracci l. Expert Rev Anticancer Ther. 2016;16(1):21-32. doi: 10.1586/14737140.2016.1123627. Expert Rev Anticancer Ther. 2016. PMID: 26588946 Review.
16 results